Clinical studies of human papilloma vaccines in cervical cancer.
Adams
M
M
University of Wales College of Medicine.
Borysiewicz
L
L
Fiander
A
A
Man
S
S
Jasani
B
B
Navabi
H
H
Evans
A S
AS
Mason
M
M
D019496:Cancer Vaccines / Q000235:genetics / Q000276:immunology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003713:Dendritic Cells / Q000276:immunology; D005260:Female; D006801:Humans; D009856:Oncogene Proteins, Viral / Q000235:genetics / Q000276:immunology / Q000627:therapeutic use; D027383:Papillomaviridae / Q000235:genetics / Q000276:immunology*; D053918:Papillomavirus Vaccines; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D002583:Uterine Cervical Neoplasms / Q000276:immunology / Q000628:therapy* / Q000821:virology; D014614:Vaccines, Synthetic; D014616:Vaccinia virus / Q000235:genetics; D014765:Viral Vaccines / Q000235:genetics / Q000276:immunology / Q000627:therapeutic use*
D019496:Cancer Vaccines; D009856:Oncogene Proteins, Viral; D053918:Papillomavirus Vaccines; D014614:Vaccines, Synthetic; D014765:Viral Vaccines; C100344:human papillomavirus vaccine, TA